FREE AND TOTAL INSULIN-LIKE GROWTH-FACTORS AND INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS DURING 14 DAYS OF GROWTH-HORMONE ADMINISTRATION IN HEALTHY-ADULTS
C. Skjaerbaek et al., FREE AND TOTAL INSULIN-LIKE GROWTH-FACTORS AND INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS DURING 14 DAYS OF GROWTH-HORMONE ADMINISTRATION IN HEALTHY-ADULTS, European journal of endocrinology, 135(6), 1996, pp. 672-677
The objective was to investigate the effect of growth hormone (GH) adm
inistration on circulating levers of free insulin-like growth factors
(IGFs) in healthy adults. Eight healthy male subjects were given place
bo and two doses of GH (3 and 6 IU/m(2) per day) for 14 days in a doub
le-blind crossover study. Fasting blood samples were obtained every se
cond day. Free TGF-I and IGF-II were determined by ultrfiltration of s
erum. Total IGF-I and IGF-II were measured after acid-ethanol extracti
on. In addition, GH, insulin, IGF binding protein I (IGFBP-1) and IGFB
P-3 were measured, Serum-free and total IGF-I increased in a dose-depe
ndent manner during the 14 days of GH administration. After 14 days, s
erum-free TGF-I values were 610 +/- 100 ng/l (mean +/- SEM) (placebo),
2760 +/- 190 ng/l (3 IU/m(2)) and 3720 +/- 240 ng/l (6 IU/m(2)) (p =
0.0001 for 3 and 6 IU/m(2) vs placebo; p = 0.004 for 3 IU/m(2) vs 6 IU
/m(2)). Total IGF-I values were 190 +/- 10 mu g/l (placebo), 525 +/- 1
0 (3 IU/m(2)), and 655 +/- 40 mu g/l (6 IU/m(2)) (p < 0.0001 tor 3 ana
6 IU/m(2) VS placebo; p = 0.04 for 3 IU/m(2) vs 6 IU/m(2)). There wer
e no differences in the levers of free or total IGF-II during the thre
e study periods. Insulin-like growth factor binding protein 1 was decr
eased during GH administration (p = 0.04 for placebo vs 3 IU/m(2); p =
0.006 for placebo vs 6 IU/m(2)). In conclusion, fasting serum free IG
F-I increased dose dependently during GH administration and free IGF-I
increased relatively more than total IGF-I. This may partly be due to
the decrease in IGFBP-1.